Xgeva 120 MG/1.7 ML vial 1.7ML
Ended Awarded
- Contract number
- SPE2DB25FXM47
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $36,804
Award facts
- Contract value 100% obligated
- $36,804.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of XGEVA 120 mg/1.7 ml vials with a ceiling value of $36.8K. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with an ultimate completion date of September 24, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9M comprehensive global pharmaceutical support vehicle that runs through December 2026 and enables the supply of a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor serving military and veteran healthcare systems through its extensive portfolio of medical product deliveries. The company maintains a track record of successfully fulfilling federal procurement requirements through open competition, with delivery orders consistently structured as firm fixed-price contracts. This particular order for XGEVA, an oncology medication, demonstrates the company's continued capability to supply specialized pharmaceutical products to support Defense Health Agency and broader federal healthcare operations. The underlying IDC vehicle provides AmerisourceBergen with the flexibility to respond to federal medical supply needs across multiple therapeutic domains on a global basis.
Quick answers
Who was awarded contract SPE2DB25FXM47?
SPE2DB25FXM47 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 23, 2025.
How much is contract SPE2DB25FXM47 worth?
The government has obligated $36,804 on SPE2DB25FXM47.
Is contract SPE2DB25FXM47 an order under another contract?
Yes. SPE2DB25FXM47 is a delivery order under SPE2DB22D3501, an indefinite delivery contract.
Was contract SPE2DB25FXM47 competed?
The extent of competition for SPE2DB25FXM47 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award